Literature DB >> 11108732

Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates.

R G Lee1, M C Willingham, M A Davis, K A Skinner, L L Rudel.   

Abstract

Two closely related enzymes with more than 50% sequence identity have been identified that catalyze the esterification of cholesterol using acyl-CoA substrates, namely acyl-CoA:cholesterol acyltransferase 1 (ACAT1) and ACAT2. Both are membrane-spanning proteins believed to reside in the endoplasmic reticulum of cells. ACAT2 has been hypothesized to be associated with lipoprotein particle secretion whereas ACAT1 is ubiquitous and may serve a more general role in cellular cholesterol homeostasis. We have prepared and affinity purified rabbit polyclonal antibodies unique to either ACAT enzyme to identify their cellular localization in liver and intestine, the two main lipoprotein-secreting tissues of the body, and for comparison, kidney and adrenal. In the liver, ACAT2 was identified in the rough endoplasmic reticulum of essentially all hepatocytes whereas ACAT1 was confined to cells lining the intercellular spaces among hepatocytes in a pattern typical of Kupffer cells. In the intestine, ACAT2 signal was strongly present in the apical third of the mucosal cells, whereas ACAT1 staining was diffuse throughout the mucosal cell, but with strong signal in goblet cells, Paneth cells, and villus macrophages. In the kidney, ACAT1 immunostaining was specific for the distal tubules and podocytes within the glomerulus. In the adrenal, ACAT1 signal was strongly present in the cells of the cortex, and absent from other adrenal cell types. No ACAT2 signal was identified in the kidney or adrenal. We conclude that only the cells of the liver and intestine that secrete apolipoprotein B-containing lipoproteins contain ACAT2, whereas ACAT1 is present in numerous other cell types. The data clearly suggest separate functions for these two closely related enzymes, with ACAT2 being most closely associated with plasma cholesterol levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108732

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  63 in total

1.  ACAT2 and ABCG5/G8 are both required for efficient cholesterol absorption in mice: evidence from thoracic lymph duct cannulation.

Authors:  Tam M Nguyen; Janet K Sawyer; Kathryn L Kelley; Matthew A Davis; Carol R Kent; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2012-06-05       Impact factor: 5.922

2.  Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestine.

Authors:  Chang Xie 谢畅; Zhang-Sen Zhou 周章森; Na Li 李钠; Yan Bian 卞艳; Yong-Jian Wang 王永建; Li-Juan Wang 王丽娟; Bo-Liang Li 李伯良; Bao-Liang Song 宋保亮
Journal:  J Lipid Res       Date:  2012-07-17       Impact factor: 5.922

3.  Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.

Authors:  Christopher M Depner; Moises Torres-Gonzalez; Sasmita Tripathy; Ginger Milne; Donald B Jump
Journal:  J Nutr       Date:  2012-06-27       Impact factor: 4.798

Review 4.  Role of the gut in modulating lipoprotein metabolism.

Authors:  Alan A Hennessy; R Paul Ross; Gerald F Fitzgerald; Noel Caplice; Catherine Stanton
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

5.  Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice.

Authors:  M Merkel; W Velez-Carrasco; L C Hudgins; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

Review 6.  Acyl-coenzyme A:cholesterol acyltransferases.

Authors:  Ta-Yuan Chang; Bo-Liang Li; Catherine C Y Chang; Yasuomi Urano
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-13       Impact factor: 4.310

7.  PRD125, a potent and selective inhibitor of sterol O-acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase-deficient mice.

Authors:  Adam M Lopez; Jen-Chieh Chuang; Kenneth S Posey; Taichi Ohshiro; Hiroshi Tomoda; Lawrence L Rudel; Stephen D Turley
Journal:  J Pharmacol Exp Ther       Date:  2015-08-17       Impact factor: 4.030

8.  Identification of the interaction site within acyl-CoA:cholesterol acyltransferase 2 for the isoform-specific inhibitor pyripyropene A.

Authors:  Akash Das; Matthew A Davis; Hiroshi Tomoda; Satoshi Omura; Lawrence L Rudel
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

9.  Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss.

Authors:  J Mark Brown; Thomas A Bell; Heather M Alger; Janet K Sawyer; Thomas L Smith; Kathryn Kelley; Ramesh Shah; Martha D Wilson; Matthew A Davis; Richard G Lee; Mark J Graham; Rosanne M Crooke; Lawrence L Rudel
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

10.  Modulation peroxisome proliferators activated receptor alpha (PPAR alpha) and acyl coenzyme A: cholesterol acyltransferase1 (ACAT1) gene expression by fatty acids in foam cell.

Authors:  Javad Zavvar Reza; Mahmoud Doosti; Masoud Salehipour; Malehieh Packnejad; Majed Mojarrad; Mansour Heidari
Journal:  Lipids Health Dis       Date:  2009-09-02       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.